Trial intelligence / Profile preview

Sonlicromanol in children with genetically confirmed mitochondrial disease

NL-OMON54867Phase 2Recruiting

Sponsor
Khondrion
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sonlicromanol in Mitochondriopathy, sponsored by Khondrion. Started Mar 2021; status: recruiting.

02

Drugs

sonlicromanol
03

Conditions

Mitochondriopathy

Beyond the preview

Go deeper on NL-OMON54867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON54867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call